Orally active 4-amino-5-diarylurea-furo[2,3-d]pyrimidine derivatives as anti-angiogenic agent inhibiting VEGFR2 and Tie-2

MLA

Daniel F. Hassler, et al. “Orally Active 4-Amino-5-Diarylurea-Furo[2,3-d]Pyrimidine Derivatives as Anti-Angiogenic Agent Inhibiting VEGFR2 and Tie-2.” Bioorganic & Medicinal Chemistry Letters, vol. 17, Mar. 2007, pp. 1773–78. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....1b824be3d8d3815226d1ad10a70e424e&authtype=sso&custid=ns315887.

APA

Daniel F. Hassler, Robert T. Nolte, Denis Patrick, Jun Tang, Masato Nakano, Kazunori Ozawa, Maureen L. Ho, Eldridge N. Nartey, Yasushi Miyazaki, Yutaka Maeda, Hideyuki Sato, Anne T. Truesdale, Masaki Sugai, Liping Wang, & Yuji Okamoto. (2007). Orally active 4-amino-5-diarylurea-furo[2,3-d]pyrimidine derivatives as anti-angiogenic agent inhibiting VEGFR2 and Tie-2. Bioorganic & Medicinal Chemistry Letters, 17, 1773–1778.

Chicago

Daniel F. Hassler, Robert T. Nolte, Denis Patrick, Jun Tang, Masato Nakano, Kazunori Ozawa, Maureen L. Ho, et al. 2007. “Orally Active 4-Amino-5-Diarylurea-Furo[2,3-d]Pyrimidine Derivatives as Anti-Angiogenic Agent Inhibiting VEGFR2 and Tie-2.” Bioorganic & Medicinal Chemistry Letters 17 (March): 1773–78. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....1b824be3d8d3815226d1ad10a70e424e&authtype=sso&custid=ns315887.